Inogen

Traded on the St. Petersburg Stock Exchange
Inogen Inc is a medical technology company that develops and manufactures portable oxygen concentrators used to deliver oxygen therapy to patients with chronic respiratory conditions.
Inogen stock price chart
-40%
P/E adj.
Net profit (adj.)
P/B
Book value
P/FCF
FCF
Yield
Growth potential

Inogen balance sheet

Report period2018 2019 2020 2021 2022 Q3 23
End date of the reporting period
Capitalization, $
Capitalization, $
Enterprise Value
Book Value
Shareholders Book Value
Current liabilities
Noncurrent liabilities
Total liabilities
Debt
Cash and cash equivalents
Net debt
Assets
Total ordinary shares
Ordinary share price

Inogen cash flows

Report period2018 2019 2020 2021 2022 Q3 23 TTM
End date of the reporting period
Sales
Gross profit
Operation Income
Earnings
Shareholders earnings
EBITDA
Adjusted EBITDA
Operation Cashflow
Capital expenditure
Free Cash Flow
EPS

Inogen multipliers

Report period2018 2019 2020 2021 2022 Q3 23 TTM
P/E
P/E adj.
E/P
E adj./P
P/B
P/S
P/FCF
L/A
Debt-To-Equity
Net Debt/EBITDA
Net Debt/EBITDA adj.
EV/EBITDA
EV/EBITDA adj.

Inogen profitability

Report period2018 2019 2020 2021 2022 Q3 23 TTM
ROA
ROE
ROS
Gross margin
EBITDA Margin
Operating margin
Inogen assets
Inogen cash flows

Inogen shares

TickerNameTypeNominal valueISINPrice
INGN:USInogen, Inc.Common share-US45780L1044$7.07
Inogen news
06.05.2022
Inogen's GAAP loss for 3 months of 2022 was $14.214 million, up 19.4 times from $0.732 million in the prior year. Revenue decreased by 7.5% to $80.385 million from $86.932 million a year earlier.
25.02.2022
Inogen's GAAP loss for 2021 was $6.333 million, up 8.6% from $5.829 million in the prior year. Revenue increased 16.1% to $358.003 million from $308.487 million a year earlier.
05.11.2021
Inogen's GAAP net income for 9M 2021 was $16.544 million, against a loss of $0.708 million in the previous year. Revenue increased 20.1% to $281.6 million from $234.509 million a year earlier.
05.08.2021
Inogen's GAAP net income for six months of 2021 was $4.37 million, up 4.4 times from $0.991 million in the prior year. Revenue increased 17.7% to $188.495 million from $160.18 million a year earlier.
General information
Company nameInogen
SectorHealth Care / Health Care Equipment & Services / Health Care Equipment & Supplies / Health Care Supplies
Business address326 BOLLAY DRIVE GOLETA CA 93117 805-562-0500
Mailing address326 BOLLAY DRIVE GOLETA CA 93117
Websitewww.inogen.com
Information disclosurewww.sec.gov